<DOC>
	<DOCNO>NCT01302067</DOCNO>
	<brief_summary>This study design confirm 8mg fesoterodine effective reduce overactive bladder symptom 4mg fesoterodine . In addition study design ass high dose reduces overall effect overactive bladder subject 's daily life lower dose . The study also assess side effect safety two dos .</brief_summary>
	<brief_title>A 12 Week Study Confirm Effectiveness 8mg Fesoterodine Compared 4mg Fesoterodine</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>6 month overactive bladder symptom , minimum 2 urgency urinary incontinence episode per 24 hour minimum 8 micturition per 24 hour . Other concurrent concomitant medication disease could put subject additional risk interfere study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>